Scientists map the Brain's electrical signatures to build a healthy reference range

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION CRITERIA 1. Any sex, at least 6 years of age or older 2. Able to understand the informed consent/assent form (in English), study procedures and willing to participate in study; participants under 19 must also have a parent/guardian who is able to understand and provide informed consent on their behalf. 3. Able to remain seated and focused for 7 minutes 4. In good health with no history of clinically relevant neurological illness or injury EXCLUSION CRITERIA 1. Requires the use of hearing aids or a cochlear implant, diagnosed with tinnitus that is currently active, or has temporary damage to hearing (e.g., punctured ear drum). Or unable to detect a 740Hz tone played at 85dB in both ears. 2. Implanted pacemaker or other electrical stimulator(s) 3. Metal or plastic implants in the skull, excluding dental/facial implants. 4. Not native-level in English 5. Previous exposure to the NeuroCatch® Platform 2 audio sequences in the last 3 months 6. History of clinically relevant neurological disorders or injury (e.g., epilepsy, Parkinson's disease, traumatic brain injury, etc.) 7. History of chronic pain or chronic headache disorders (e.g. migraine, tension headaches, fibromyalgia, etc.) 8. Currently diagnosed with any sleeping disorders (e.g. sleep apnea, hypersomnia, insomnia, parasomnia, etc.) 9. Diagnosed with any memory disorders. 10. History of clinically relevant major psychiatric disorders (e.g., schizophrenia, bipolar disorder, etc.) 11. History of alcohol or substance misuse that, in the opinion of the Investigator, may impact brain function 12. Use of medications that affect brain function (e.g., antiepileptic drugs, antipsychotics, stimulants, etc.) 13. Serious medical conditions affecting brain functions (e.g., stroke, brain tumor, neurodegenerative diseases, etc.) 14. Undergoing chemotherapy or any form of intensive long-term therapy that, in the opinion of the Investigator, may impact brain function. 15. Unhealthy scalp (e.g., apparent open wounds and/or bruised or weakened skin) 16. Allergy to EEG gel